Amarin Corp Plc (AMRN)

[Atom0aks]

Atom are U suggesting that the FDA will not include diabetics with 1 additional risk factor because the RRR is ONLY 12% ??

Yes.

Ezetimibe is approved for what I recall is even less the that .

As far as I'm aware, Ezetimibe is indicated for dyslipidemia, not CVD (as Amarin is looking for).

Its a risk / benefit analysis based on data . What the risk for including these primary prevention diabetic ....?

The FDA is not typically known to approve labels on the basis of, "what's the worse that could happen?"